Q4 2024 Holdings
Filed 2025-02-14 | 47 holdings | $854.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $77.1M | 3,000,000 | 9.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $66.9M | 1,250,000 | 7.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $63.4M | 1,450,000 | 7.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $42.3M | 900,000 | 5.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $37.0M | 875,000 | 4.3% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $34.2M | 300,000 | 4.0% |
| Merus N V | COM | N5749R100 | $31.5M | 750,000 | 3.7% |
| Erasca Inc(ERAS) | COM | 29479A108 | $31.4M | 12,500,000 | 3.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $31.1M | 450,000 | 3.6% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $29.9M | 3,500,000 | 3.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $27.3M | 200,000 | 3.2% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $26.0M | 4,217,627 | 3.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $24.6M | 300,000 | 2.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $22.3M | 800,000 | 2.6% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $21.6M | 175,000 | 2.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $19.0M | 700,000 | 2.2% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $18.7M | 3,208,875 | 2.2% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $17.4M | 200,000 | 2.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $17.4M | 1,000,000 | 2.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $16.0M | 500,000 | 1.9% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $15.7M | 350,000 | 1.8% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $14.4M | 500,000 | 1.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $13.6M | 300,000 | 1.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $13.4M | 700,000 | 1.6% |
| Annexon Inc(ANNX) | COM | 03589W102 | $13.1M | 2,550,000 | 1.5% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $12.7M | 200,000 | 1.5% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $11.6M | 500,000 | 1.4% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $10.7M | 400,000 | 1.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $10.6M | 450,000 | 1.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $9.9M | 750,000 | 1.2% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $8.8M | 245,000 | 1.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $7.8M | 1,000,000 | 0.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $7.4M | 300,000 | 0.9% |
| Geron Corp(GERN) | COM | 374163103 | $7.1M | 2,000,000 | 0.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $5.5M | 2,222,222 | 0.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $5.2M | 1,250,000 | 0.6% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $4.5M | 500,000 | 0.5% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $4.0M | 5,078,927 | 0.5% |
| Aerovate Therapeutics Inc | COM | 008064107 | $3.7M | 1,400,000 | 0.4% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $3.7M | 208,910 | 0.4% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $3.6M | 1,000,000 | 0.4% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $3.5M | 2,900,000 | 0.4% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $3.2M | 140,000 | 0.4% |
| Septerna Inc(SEPN) | COM | 81734D104 | $3.1M | 134,202 | 0.4% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $1.5M | 145,089 | 0.2% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $1.3M | 5,400,000 | 0.2% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 02/10/202 | 67080N119 | $15.3K | 66,666 | 0.0% |